Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-Ribazole-5'-Phosphate Derivative, also known as alpha-Ribazole 5'-phosphate, is a chemical compound classified as a ribose monophosphate, a 1-ribosylbenzimidazole, and a dimethylbenzimidazole. It serves as a metabolite in organisms such as *Escherichia coli* and mice. This compound plays a crucial role as an intermediate in the biosynthetic pathway of cobalamin (vitamin B12) in bacteria, specifically within the nucleotide loop assembly pathway. It is formed through the activation of 5,6-dimethylbenzimidazole (DMB) into its alpha ribotide, a reaction catalyzed by phosphoribosyltransferase. While primarily a biochemical intermediate, it has been identified as a drug candidate with experimental status and is listed within pharmaceutical databases, suggesting potential therapeutic interest or its role as a component in drug-related research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alpha-Ribazole-5'-Phosphate Derivative.